877 - 888 of 7613 results

Early Recognition of axSpA in Primary Care Chapter 3: Disease burden in axSpA patients

Industry Webcast Sponsored by Novartis Pharmaceutical Corporation, LLC; Not for CME/CE Credit

View this presentation to learn more about the important role of primary care providers in the early recognition of axSpA. This presentation is the third chapter of a series of videos exploring axSpA. Join us for a live webinar with Dr. Jain on October 27 at 12:40 PM ET.


Acute Exacerbations: Predictors of Poor Outcomes in COPD

Industry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit

This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.


Stomach intestines

Pancreatic Cancer & Primary Care: Considerations for Earlier Diagnosis

Industry Webcast Sponsored by Immunovia; Not for CME/CE Credit

During this presentation, Dr. Randall Brand, an interventional gastroenterologist, will review which patients are at highest risk for developing pancreatic cancer and how primary care providers can assist those patients. Dr. Brand will also review what clinical symptoms should raise suspicion for pancreatic cancer, with the goal of helping to identify pancreatic cancer at earlier stages.


Do you want more information on continuous glucose monitoring (also known as “CGM”) or wonder if continuous glucose monitoring can help you better manage your diabetes? Listen to this podcast hosted by two diabetes education specialists, Diana Isaacs, PharmD, and Patricia Montesinos, NP, as they discuss common questions from people with diabetes about continuous glucose monitoring. The pair will start by reviewing what CGM is, how it works, and describe the different types of CGM devices and how they are used. Then they will move on to discuss topics including the pros and cons of CGM, who qualifies for CGM, common questions about using CGM devices, and how to decide about which device might be right for you. Please note that information in this podcast is not meant to replace the guidance of your doctor or diabetes healthcare team. Please consult a medical professional regarding whether CGM is a good choice for you. Any device information, indications, and guidelines presented in this activity are current as of the recording on 10/22/2020 and they are subject to change as new information is published.


Do you use continuous glucose monitoring (also known as “CGM”) or care for someone who does? Listen to this podcast hosted by two diabetes education specialists, Diana Isaacs, PharmD, and Patricia Montesinos, NP, as they review important information regarding the currently available CGM devices and discuss common issues and questions that arise for people with diabetes using CGM. The pair will begin by reviewing important information about CGM devices for people starting out and will address common questions about using CGM. This will be followed by discussion of more advanced topics, including when to call your healthcare team about your device or the glucose data on your device, and how to approach making insulin and dietary adjustments based on glucose data from a CGM device. Please note that information in this podcast is not meant to replace the guidance of your doctor or diabetes healthcare team. Please consult a medical professional regarding whether CGM is a good choice for you. Any device information, indications, and guidelines presented in this activity are current as of the recording on 10/22/2020 and they are subject to change as new information is published.


0.25 CME CREDIT

GLP-1 Receptor Agonists: A Cardiology Perspective (Podcast)

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. Dr. Gluckman will bring the perspective of a cardiologist into the discussion of these agents with emerging significance in cardiovascular risk reduction.


0.3 CME CREDIT

Adults between the ages of 18 through 64 with immunocompromising conditions due to either anatomic defects or impaired immune response are at the highest risk for invasive pneumococcal disease. They need two different pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) at the time the risk factor is recognized and pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks later. This podcast will discuss how to identify these patients at high risk for pneumococcal disease and implement guidelines for administration of pneumococcal vaccination in this population. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


0.25 CME CREDIT

A Big Change for the 2021 Medicare Physician Fee Schedule: New Guidance on Coding

Guest: Robert Baldor, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.


0.28 CME CREDIT

Most patients between ages 18 and 64 presenting to primary care practices have a comorbidity that increases their risk for invasive pneumococcal disease and thus warrants immunization. These comorbidities include diabetes, cardiovascular disease, respiratory disease (such as asthma or COPD), liver disease, smoking, and others. This podcast will discuss the recommendations for pneumococcal vaccines in this population.


0.75 CME CREDIT

Treating Patients with Anemia of CKD

0.75 CME
0.70 AANP | 0.70 Pharmacology

The goal of this activity is to understand the challenges of individualized management of CKD-related anemia with a focus on strategies for making treatment decisions and patient-centric treatment plans. Unmet needs of treating anemia of CKD will also be discussed.


0.5 CME CREDIT

Treating chronic pain in older individuals and balancing analgesia and adverse effects in this population, which is often afflicted with multiple comorbidities, is challenging. This program reviews the assessment and nonpharmacologic treatment of chronic pain in patients aged 65 years and older. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.292 CME CREDIT

The vast majority of opioid overdoses are inadvertent. While not a substitute for emergency medical care, naloxone can reduce the risk of opioid overdose mortality. It is important for medical professionals, patients, and families to become familiar with naloxone use.